Illumina next-generation sequencing (NGS) has been the most widely adopted technology for human whole-genome sequencing (WGS), delivering an accurate, scalable, cost-effective solution, featured in over 300,000 scientific publications. However, a small portion of the genome remains challenging to map due to highly repetitive or highly homologous regions. Illumina Complete Long-Read technology, previously announced as Infinity, will address these edge cases and accelerate access to the remaining ~5% of genic regions.
In this recorded presentation from our ASHG 2022 CoLab talk, we describe the benefits of Illumina’s novel long-read technology, including accuracy, scalability, and workflow improvements. In addition, we discuss how the Complete Long-Read technology is complemented by other technical innovations in our roadmap.
Sr. Manager, Product Management
Your email address is never shared with third parties.